Loading...
Cann Group Limited
CNGGF•PNK
HealthcareDrug Manufacturers - Specialty & Generic
$0.006
$0.00(0.00%)
Cann Group Limited (CNGGF) Financial Performance & Statements
Review Cann Group Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
11.58%
↑ 11.58%
Operating Income Growth
63.82%
↑ 63.82%
Net Income Growth
-51.65%
↓ 51.65%
Operating Cash Flow Growth
33.50%
↑ 33.50%
Operating Margin
-114.17%
↓ 114.17%
Gross Margin
-42.09%
↓ 42.09%
Net Profit Margin
-292.38%
↓ 292.38%
ROE
-159.56%
↓ 159.56%
ROIC
-137.75%
↓ 137.75%
Cann Group Limited (CNGGF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Cann Group Limited stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $9.04M | $8.49M | $7.96M | $5.82M |
| Cost of Revenue | $7.16M | $17.74M | -$4.06M | $5.97M |
| Gross Profit | $1.88M | -$9.25M | $12.02M | -$152000.00 |
| Gross Profit Ratio | $0.21 | -$1.09 | $1.51 | -$0.03 |
| R&D Expenses | $375000.00 | $380000.00 | $1.72M | $2.57M |
| SG&A Expenses | $6.87M | $5.009M | $16.68M | $16.68M |
| Operating Expenses | $7.24M | $5.39M | $19.63M | $19.45M |
| Total Costs & Expenses | $14.40M | $23.13M | $25.50M | $25.53M |
| Interest Income | $0.00 | $16000.00 | $1.79M | $1.37M |
| Interest Expense | $4.56M | $2.26M | $1.79M | $1.37M |
| Depreciation & Amortization | $5.34M | $5.70M | $5.87M | $6.09M |
| EBITDA | -$5.37M | -$6.41M | -$6.93M | -$10.83M |
| EBITDA Ratio | -$0.59 | -$1.05 | -$1.47 | -$2.34 |
| Operating Income | -$5.37M | -$14.64M | -$17.54M | -$19.71M |
| Operating Income Ratio | -$0.59 | -$1.73 | -$2.20 | -$3.39 |
| Other Income/Expenses (Net) | -$33.66M | $276000.00 | -$840000.00 | -$1.65M |
| Income Before Tax | -$39.02M | -$14.37M | -$18.38M | -$21.36M |
| Income Before Tax Ratio | -$4.32 | -$1.69 | -$2.31 | -$3.67 |
| Income Tax Expense | -$2.12M | -$29000.00 | -$3.44M | -$2.52M |
| Net Income | -$36.90M | -$14.34M | -$14.95M | -$18.84M |
| Net Income Ratio | -$4.08 | -$1.69 | -$1.88 | -$3.24 |
| EPS | -$0.08 | -$0.03 | -$0.04 | -$0.05 |
| Diluted EPS | -$0.08 | -$0.03 | -$0.04 | -$0.05 |
| Weighted Avg Shares Outstanding | $437.60M | $421.14M | $388.61M | $355.58M |
| Weighted Avg Shares Outstanding (Diluted) | $437.63M | $421.14M | $388.61M | $355.58M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan